OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Menopausal Symptoms reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,252 reports · 50 co-occurring drugs

As of the last recalculation, Menopausal Symptoms appears in 2,252 FAERS reports alongside 50 co-occurring drug terms. The strongest observed disproportionality signal is ESTRADIOL (PRR 58.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Estradiol44058.358.6
Estradiol Gel 0.1%23453.353.6
Estradiol Transdermal23453.353.5
Goserelin4531.631.7
Progesterone4920.220.3
Lanreotide Acetate1315.415.4
Orlistat3914.114.2
Letrozole Tablets6613.013.1
Letrozole8012.412.4
Anastrozole4511.511.6
Telmisartan2111.011.0
Anastrozole Tablets2510.910.9
Estrogens, Conjugated6310.110.1
Conjugated Estrogens599.69.6
Methadone Hydrochloride119.49.4
Standardized Senna Concentrate128.98.9
Exemestane198.38.3
Thyroid, Porcine97.87.8
Liothyronine Sodium77.47.5
Ribociclib257.47.4
Conjugated Estrogens And Medroxyprogesterone Acetate187.17.1
Fluoxetine507.17.1
Fexofenadine Hcl77.07.0
Meloxicam416.66.6
Naltrexone Hydrochloride And Bupropion Hydrochloride66.56.5
Abemaciclib136.06.0
Ibuprofen Tablets, Coated255.55.5
Ibuprofen Sodium255.45.4
Copper255.45.4
Denosumab1085.15.1
Leuprolide Acetate425.15.1
Medroxyprogesterone Acetate264.94.9
Etonogestrel And Ethinyl Estradiol114.64.6
Niraparib114.64.6
Dimethyl Fumarate584.44.4
Levonorgestrel934.44.4
Palbociclib414.04.0
Diroximel Fumarate53.93.9
Asfotase Alfa43.73.7
Docetaxel Anhydrous253.53.5
Docetaxel253.53.5
Relugolix83.13.1
Siponimod33.13.1
Avapritinib43.13.1
Lapatinib53.03.0
Drospirenone And Ethinyl Estradiol142.92.9
Dornase Alfa52.42.4
Natalizumab452.32.3
Erenumab-Aooe122.02.0
Etonogestrel91.71.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.